• Ajoutez une description, des images, des menus et des liens à votre méga-menu

  • Une colonne sans paramètres peut être utilisée comme un espaceur

  • Lien vers vos collections, vos ventes et même des liens externes

  • Ajoutez jusqu'à cinq colonnes

  • mai 30, 2017 2 lire la lecture

    Despite encouraging declines in maternal mortality over the last two decades, women in resource-poor areas of the world still bear a disproportionate burden. Worldwide, around 10 million women develop preeclampsia each year and about 10-25% of cases in developing countries lead to death. Women in developing countries bear a disproportionate burden - they are seven times more likely to experience preeclampsia than a woman in developed countries.


    Preeclampsia is a disorder defined clinically by hypertension and proteinuria, with or without pathologic edema, and can progress to eclampsia. Eclampsia is a serious condition that can cause seizures, kidney and liver damage, and death. There are currently no ways to accurately predict preeclampsia, but urinalysis and blood pressure readings can be used to diagnose the disorder. In place where resources are scarce, urine dipsticks are used instead of urinalysis, but results are not always reliable. 

    In response to these problems, Maternova partnered with HOPE Foundation Bangladesh to conduct a study looking at the feasibility of a novel urinalysis technology powered by an Android device and cuboid light box called the uChek device. Funded by Merck for Mothers, the study took place at a rural hospital in Ramu, Cox’s Bazar, Bangladesh, near the country’s border with Myanmar, and aimed to look at whether midwives could effectively use the device to conduct enhanced urinalysis.  At the beginning of the study, half of the midwives found the device to be “daunting”, but at the end of the study, all of them agreed that the uChek provided faster and more reliable results. Furthermore, these results showed that these smartphone enabled medical devices could be incorporated with minimal additional training or resources - important considerations in places without a lot of resources. 

    Devices such as the uChek can prove to be invaluable in early diagnoses of preeclampsia, which in turn can mean many saved lives. Early diagnosis can allow for better planning and preparation; for example, if warning signs are detected at 20 weeks gestation, the device can be programmed to prompt the provider to prescribe the appropriate supplements, frequent antenatal checks, and to plan with an obstetrician for special preparations during and post-delivery. This study adds to the growing body of evidence showing that smartphone technology is becoming an increasingly important tool for medical diagnosis in remote areas.

     

    blog by Vivian Shih

    Laisser un commentaire

    Les commentaires sont approuvés avant leur publication.


    Voir l'article entier

    Medical Devices for Hospitals and NGOs: How to Source the Right products for Maternal and Newborn Care
    Dispositifs médicaux pour les hôpitaux et les ONG : comment acheter les bons produits pour les soins maternels et néonatals

    juin 30, 2026 13 lire la lecture

    Voir l'article entier
    The High Quality Maternova Non-pneumatic anti-shock garment (NASG)
    Le vêtement antichoc non pneumatique (NASG) Maternova de haute qualité

    mai 25, 2026 1 lire la lecture

    Des vêtements antichoc non-pneumatiques (NASG) de haute qualité, conformes à la norme ISO 13485 et marqués CE, produits par Maternova pour être utilisés par les sages-femmes et les obstétriciens du monde entier afin de sauver des vies menacées par l'hémorragie post-partum. Nos NASG respectent les normes les plus strictes et sont approuvés par des centaines de cliniciens.

    Voir l'article entier
    A $.03 pill that could prevent maternal deaths; Part 4
    Une pilule à 0,03 $ qui pourrait prévenir les décès maternels ; 4ème partie

    mai 25, 2026 3 lire la lecture

    L'USPSTF, l'ACOG, la Society for Maternal-Fetal Medicine et la FIGO recommandent toutes l'aspirine à faible dose (LDA) pour les grossesses à haut risque. Les obstacles sont systémiques, comportementaux et structurels.

    Voir l'article entier